US Biotest, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.usbiotest.com
Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
- Conditions
- COVID-19 Virus InfectionSARS Coronavirus 2 InfectionSARS-CoV-2 Infection2019 Novel Coronavirus InfectionRespiratory Distress Syndrome, AdultAdult Respiratory Distress Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT04778059
- Locations
- 🇺🇸
The University of Arizona Health Sciences Center/ Banner Healthcare Systems Hospitals, Tucson, Arizona, United States
Study of the Safety of USB005 in Healthy Volunteers
- Conditions
- Healthy Volunteers
- Interventions
- Drug: USB005 (aclerastide) Ophthalmic SolutionDrug: USB005 Ophthalmic Solution Placebo
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2019-04-04
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03615196
- Locations
- 🇺🇸
WCCT Global, Inc., Cypress, California, United States
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
- Conditions
- Foot Ulcer, DiabeticDiabetic Foot
- Interventions
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2012-09-27
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT00796744
- Locations
- 🇺🇸
Southern Arizona VA Health Care System, Tucson, Arizona, United States
🇺🇸Southern Arizona Limb Salvage Alliance (SALSA), Tucson, Arizona, United States
🇺🇸Bay Area Footcare, Castro Valley, California, United States
Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
- First Posted Date
- 2008-09-23
- Last Posted Date
- 2012-02-29
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT00757250
- Locations
- 🇺🇸
LAC+USC Medical Center, Rand Schrader Clini, Los Angeles, California, United States
🇺🇸UCSD Division of Infectious Diseases, San Diego, California, United States
🇺🇸Harbor - UCLA Medical Center, Torrance, California, United States